International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 1 , Pages 3-10 , 1 September 2010

Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: Report of the ASTRO Emerging Technology Committee

  • Mark K. Buyyounouski, M.D., M.S.

      Affiliations

    • Fox Chase Cancer Center, Philadelphia, PA
    • Corresponding Author InformationReprint requests to: Mark K. Buyyounouski, M.D., M.S., Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111. Tel: (215) 214-3707; Fax: (215) 214-1629
    • ,
  • Peter Balter, Ph.D.

      Affiliations

    • University of Texas, MD Anderson Cancer Center, Houston, TX
    • ,
  • Brett Lewis, M.D., Ph.D.

      Affiliations

    • Cancer Institute of New Jersey, New Brunswick, NJ
    • ,
  • David J. D'Ambrosio, M.D.

      Affiliations

    • Saint Barnabas Health Care System, Toms River, NJ
    • ,
  • Thomas J. Dilling, M.D.

      Affiliations

    • H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
    • ,
  • Robert C. Miller, M.D.

      Affiliations

    • Mayo Clinic and Mayo Foundation, Rochester, MN
    • ,
  • Tracey Schefter, M.D.

      Affiliations

    • University of Colorado Health Services, Boulder, CO
    • ,
  • Wolfgang Tomé, Ph.D.

      Affiliations

    • University of Wisconsin, Madison, WI
    • ,
  • Eleanor E.R. Harris, M.D.

      Affiliations

    • H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
    • ,
  • Robert A. Price Jr., Ph.D.

      Affiliations

    • Fox Chase Cancer Center, Philadelphia, PA
    • ,
  • Andre A. Konski, M.D., M.B.A.

      Affiliations

    • Wayne State University School of Medicine, Detroit, MI
    • ,
  • Paul E. Wallner, D.O.

      Affiliations

    • 21st Century Oncology, Inc, Moorestown, NJ

Received 30 March 2010 ,Revised 2 April 2010 ,Accepted 2 April 2010.

References 

  1. Hugo GD, Yan D, Liang J. Population and patient-specific target margins for 4D adaptive radiotherapy to account for intra- and inter-fraction variation in lung tumor position. Phys Med Biol. 2007;52:257–274
  2. Liu HH, Balter P, Tutt T, et al. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys. 2007;68:531–540
  3. Shirato H, Seppenwoolde Y, Kitamura K, et al. Intrafractional tumor motion: Lung and liver. Semin Radiat Oncol. 2004;14:10–18
  4. Shirato H, Suzuki K, Sharp GC, et al. Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys. 2006;64:1229–1236
  5. Zhang T, Orton NP, Tome WA. On the automated definition of mobile target volumes from 4D-CT images for stereotactic body radiotherapy. Med Phys. 2005;32:3493–3502
  6. Underberg RW, Lagerwaard FJ, Cuijpers JP, et al. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:1283–1290
  7. Rietzel E, Pan T, Chen GT. Four-dimensional computed tomography: Image formation and clinical protocol. Med Phys. 2005;32:874–889
  8. Chang JY, Balter P, Liao Z, et al. Preliminary report of image-guided hypofractionated stereotactic body radiotherapy to treat patients with medically inoperable stage I or isolated peripheral lung recurrent non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;66:S480–S481
  9. Hodge W, Tome WA, Jaradat HA, et al. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation. Acta Oncol. 2006;45:890–896
  10. Murray B, Forster K, Timmerman R. Frame-based immobilization and targeting for stereotactic body radiation therapy. Med Dosim. 2007;32:86–91
  11. Nelson C, Starkschall G, Balter P, et al. Respiration-correlated treatment delivery using feedback-guided breath hold: A technical study. Med Phys. 2005;32:175–181
  12. Shirato H, Shimizu S, Kunieda T, et al. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1187–1195
  13. D'Souza WD, Nazareth DP, Zhang B, et al. The use of gated and 4D CT imaging in planning for stereotactic body radiation therapy. Med Dosim. 2007;32:92–101
  14. Wong JW, Sharpe MB, Jaffray DA, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys. 1999;44:911–919
  15. Kamino Y, Takayama K, Kokubo M, et al. Development of a four-dimensional image-guided radiotherapy system with a gimbaled X-ray head. Int J Radiat Oncol Biol Phys. 2006;66:271–278
  16. Keall PJ, Joshi S, Vedam SS, et al. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys. 2005;32:942–951
  17. Neicu T, Shirato H, Seppenwoolde Y, et al. Synchronized moving aperture radiation therapy (SMART): Average tumour trajectory for lung patients. Phys Med Biol. 2003;48:587–598
  18. Nuyttens JJ, Prevost JB, Praag J, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results. Acta Oncol. 2006;45:961–965
  19. Lohr F, Debus J, Frank C, et al. Noninvasive patient fixation for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:521–527
  20. Hadinger U, Thiele W, Wulf J. Extracranial stereotactic radiotherapy: Evaluation of PTV coverage and dose conformity. Z Med Phys. 2002;12:221–229
  21. Starkschall G, Forster KM, Kitamura K, et al. Correlation of gross tumor volume excursion with potential benefits of respiratory gating. Int J Radiat Oncol Biol Phys. 2004;60:1291–1297
  22. Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys. 2005;62:554–560
  23. Zhang T, Keller H, O'Brien MJ, et al. Application of the spirometer in respiratory gated radiotherapy. Med Phys. 2003;30:3165–3171
  24. Yin FF, Zhu J, Yan H, et al. Dosimetric characteristics of Novalis shaped beam surgery unit. Med Phys. 2002;29:1729–1738
  25. Adler JR, Chang SD, Murphy MJ, et al. The Cyberknife: A frameless robotic system for radiosurgery. Stereotact Funct Neurosurg. 1997;69:124–128
  26. Shirato H, Shimizu S, Shimizu T, et al. Real-time tumour-tracking radiotherapy. Lancet. 1999;353:1331–1332
  27. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). vol 62. Bethesda, MD: International Commission on Radiation Units and Measurements; 1999;
  28. Lax I, Panettieri V, Wennberg B, et al. Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. Acta Oncol. 2006;45:978–988
  29. Kavanagh BD, Timmerman RD, Benedict SH, et al. How should we describe the radiobiologic effect of extracranial stereotactic radiosurgery: Equivalent uniform dose or tumor control probability?. Med Phys. 2003;30:321–324
  30. Chang BK, Timmerman RD. Stereotactic body radiation therapy: A comprehensive review. Am J Clin Oncol. 2007;30:637–644
  31. Panettieri V, Wennberg B, Gagliardi G, et al. SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems. Phys Med Biol. 2007;52:4265–4281
  32. Morgan AM, Knoos T, McNee SG, et al. Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. Radiother Oncol. 2008;86:48–54
  33. Davidson SE, Ibbott GS, Prado KL, et al. Accuracy of two heterogeneity dose calculation algorithms for IMRT in treatment plans designed using an anthropomorphic thorax phantom. Med Phys. 2007;34:1850–1857
  34. Gagne IM, Zavgorodni S. Evaluation of the analytical anisotropic algorithm in an extreme water-lung interface phantom using Monte Carlo dose calculations. J Appl Clin Med Phys. 2007;8:33–46
  35. Buyyounouski MK, Price RA, Harris EE, et al. Stereotactic body radiotherapy (SBRT) for primary management of early-stage, low-intermediate risk prostate cancer: Report of the ASTRO Emerging Technology Committee (ETC). Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1297–1304
  36. Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132:161S–177S
  37. Timmerman R, Michalski J, Fowler J, et al. RTOG 0236: A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. Proceedings of the 13th World Conference on Lung Cancer, San Francisco, CA, July 31 - August 4, 2009.
  38. McGarry RC, Song G, des Rosiers P, et al. Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest. 2002;121:1155–1158
  39. Scott WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:234S–242S
  40. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev. 2001;CD002935
  41. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:318–328
  42. Narayan S, Henning GT, Ten Haken RK, et al. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer. 2004;44:79–88
  43. Belderbos JS, Heemsbergen WD, De Jaeger K, et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:126–134
  44. Cesaretti JA, Pennathur A, Rosenstein BS, et al. Stereotactic radiosurgery for thoracic malignancies. Ann Thorac Surg. 2008;85:S785–S791
  45. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005;8:89–91
  46. Fowler JF, Tomé WA, Fenwick JD, et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys. 2004;60:1241–1256
  47. Hall E. Radiobiology for the radiologist. 4th ed.. Philadelphia: J.B Lippincott; 1994;
  48. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma. Cancer. 2004;101:1623–1631
  49. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys. 2005;63:1010–1015
  50. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839
  51. Beitler JJ, Badine EA, El-Sayah D, et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys. 2006;65:100–106
  52. Feigenberg S, Sharma N, Wang L, Cohen R, Buyyounouski M, Lally B, et al. Phase I dose escalation trial of image guided stereotactic body radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys. 2008;72:S114
  53. Sharma N, Ruth K, Konski A, Buyyounouski MK, Nicolaou N, Lally BE, et al. Low morbidity and excellent local control using image guided stereotactic body radiotherapy (IGSBRT) for lung tumors. Int J Radiat Oncol Biol Phys. 2008;72:S454
  54. Yoon SM, Choi EK, Lee SW, et al. Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol. 2006;45:1108–1114
  55. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427–1431
  56. Nyman J, Johansson K-A, Hultén U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer: Mature results for medically inoperable patients. Lung Cancer. 2006;51:97–103
  57. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787–795
  58. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer. 2005;48:107–114
  59. Henderson M, McGarry R, Yiannoutsos C, et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):404–409
  60. Ohashi T, Takeda A, Shigematsu N, et al. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors. Int J Radiat Oncol Biol Phys. 2005;62:1003–1008
  61. Paludan M, Hansen AT, Petersen J, et al. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?. Acta Oncologica. 2006;45:818–822
  62. Bradley J. Radiographic response and clinical toxicity following SBRT for stage I lung cancer. J Thorac Oncol. 2007;2:S118–S124
  63. Kimura T, Matsuura K, Murakami Y, et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers?. Int J Radiat Oncol Biol Phys. 2006;66:483–491
  64. Matsuo Y, Nakamoto Y, Nagata Y, et al. Characteristics of FDG-PET images after stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2006;S471
  65. Hoopes DJ, Fletcher J, Tann M, et al. A prospective trial of serial FGD-PET in patients with medically inoperable stage I non-small cell lung cancer treated with hypofractionated stereotactic body radiotherapy (SBRT). Int J Radiat Oncol Biol Phys. 2006;66:S25–S26
  66. Hoopes D, Tann M, Lo S, et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2005;63:S225
  67. Timmerman R, Paulus R, Galvin J, et al. RTOG 0236: Stereotactic body radiation therapy to treat medically inoperable early stage lung cancer patients. J Thorac Oncol. 2009;4:S299–S300
  68. Le QT, Loo BW, Ho A, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006;1:802–809
  69. Fritz P, Kraus HJ, Muhlnickel W, et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol. 2006;1:30
  70. Hara R, Itami J, Kondo T, et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer. 2006;106:1347–1352
  71. Pennathur A, Luketich JD, Burton S, et al. Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience. Ann Thorac Surg. 2007;83:1820–1825
  72. California Technology Assessment Forum. Stereotactic body radiation therapy for the treatment of early stage non small cell lung cancer. Available at www.ctaf.org. last accessed July 8, 2010.2008.

 Conflict of interest: none.

PII: S0360-3016(10)00528-6

doi: 10.1016/j.ijrobp.2010.04.010

International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 1 , Pages 3-10 , 1 September 2010

Article Tools